Quantitative telomeric chromatin isolation protocol for human cells

Methods

Volumn 114, Issue , 2017, Pages 28-38

  Majerská, Jana ^a   Redon, Sophie ^a   Lingner, Joachim ^a  

^a EPFL   (Switzerland)

Author keywords

Affinity purification; Chromatin; Mass spectrometry; SILAC; Telomeres

Indexed keywords

AMINO ACID; CROSS LINKING REAGENT;

ARTICLE; CELL CULTURE; CELL ISOLATION; CHROMATIN; CLINICAL PROTOCOL; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; ISOTOPE LABELING; MASS SPECTROMETRY; NONHUMAN; PURIFICATION; QUANTITATIVE GENETICS; QUANTITATIVE TELOMERIC CHROMATIN ISOLATION PROTOCOL; TELOMERE; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; HELA CELL LINE; ISOLATION AND PURIFICATION; PROCEDURES;

CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CROSS-LINKING REAGENTS; HELA CELLS; HUMANS; ISOTOPE LABELING; MASS SPECTROMETRY; TELOMERE;

EID: 84981743109     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2016.08.003     Document Type: Article

References (56)

1. [1] de Lange, T., How telomeres solve the end-protection problem. Science 326:5955 (2009), 948–952.
2. [2] Baumann, P., Cech, T., Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292 (2001), 1171–1175.
3. [3] Sfeir, A., de Lange, T., Removal of shelterin reveals the telomere end-protection problem. Science 336:6081 (2012), 593–597.
4. [4] Sfeir, A., Kosiyatrakul, S.T., Hockemeyer, D., MacRae, S.L., Karlseder, J., Schildkraut, C.L., de Lange, T., Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138:1 (2009), 90–103.
5. [5] Miller, K.M., Rog, O., Cooper, J.P., Semi-conservative DNA replication through telomeres requires Taz1. Nature 440:7085 (2006), 824–828.
6. [6] Abreu, E., Aritonovska, E., Reichenbach, P., Cristofari, G., Culp, B., Terns, R.M., Lingner, J., Terns, M.P., TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol. Cell. Biol. 30:12 (2010), 2971–2982.
7. [7] Zhong, F.L., Batista, L.F., Freund, A., Pech, M.F., Venteicher, A.S., Artandi, S.E., TPP1 OB-Fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Cell 150:3 (2012), 481–494.
8. [8] Nandakumar, J., Bell, C.F., Weidenfeld, I., Zaug, A.J., Leinwand, L.A., Cech, T.R., The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature 492:7428 (2012), 285–289.
9. [9] Sexton, A.N., Regalado, S.G., Lai, C.S., Cost, G.J., O'Neil, C.M., Urnov, F.D., Gregory, P.D., Jaenisch, R., Collins, K., Hockemeyer, D., Genetic and molecular identification of three human TPP1 functions in telomerase action: recruitment, activation, and homeostasis set point regulation. Genes Dev. 28:17 (2014), 1885–1899.
10. [10] Kocak, H., Ballew, B.J., Bisht, K., Eggebeen, R., Hicks, B.D., Suman, S., O'Neil, A., Giri, N., Maillard, I., Alter, B.P., Keegan, C.E., Nandakumar, J., Savage, S.A., Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1. Genes Dev. 28:19 (2014), 2090–2102.
11. [11] Savage, S.A., Giri, N., Baerlocher, G.M., Orr, N., Lansdorp, P.M., Alter, B.P., TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am. J. Hum. Genet. 82:2 (2008), 501–509.
12. [12] Walne, A.J., Vulliamy, T., Beswick, R., Kirwan, M., Dokal, I., TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood 112:9 (2008), 3594–3600.
13. [13] Takai, H., Jenkinson, E., Kabir, S., Babul-Hirji, R., Najm-Tehrani, N., Chitayat, D.A., Crow, Y.J., de Lange, T., A POT1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus. Genes Dev. 30:7 (2016), 812–826.
14. [14] Guo, Y., Kartawinata, M., Li, J., Pickett, H.A., Teo, J., Kilo, T., Barbaro, P.M., Keating, B., Chen, Y., Tian, L., Al-Odaib, A., Reddel, R.R., Christodoulou, J., Xu, X., Hakonarson, H., Bryan, T.M., Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood 124:18 (2014), 2767–2774.
15. [15] Ramsay, A.J., Quesada, V., Foronda, M., Conde, L., Martinez-Trillos, A., Villamor, N., Rodriguez, D., Kwarciak, A., Garabaya, C., Gallardo, M., Lopez-Guerra, M., Lopez-Guillermo, A., Puente, X.S., Blasco, M.A., Campo, E., Lopez-Otin, C., POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat. Genet. 45:5 (2013), 526–530.
16. [16] Pinzaru, A.M., Hom, R.A., Beal, A., Phillips, A.F., Ni, E., Cardozo, T., Nair, N., Choi, J., Wuttke, D.S., Sfeir, A., Denchi, E.L., Telomere replication stress induced by POT1 inactivation accelerates tumorigenesis. Cell Rep. 15:10 (2016), 2170–2184.
17. [17] Miyake, Y., Nakamura, M., Nabetani, A., Shimamura, S., Tamura, M., Yonehara, S., Saito, M., Ishikawa, F., RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway. Mol. Cell 36:2 (2009), 193–206.
18. [18] Surovtseva, Y.V., Churikov, D., Boltz, K.A., Song, X., Lamb, J.C., Warrington, R., Leehy, K., Heacock, M., Price, C.M., Shippen, D.E., Conserved telomere maintenance component 1 interacts with STN1 and maintains chromosome ends in higher eukaryotes. Mol. Cell 36:2 (2009), 207–218.
19. [19] Wu, P., Takai, H., de Lange, T., Telomeric 3’ overhangs derive from resection by Exo1 and Apollo and Fill-In by POT1b-associated CST. Cell 150:1 (2012), 39–52.
20. [20] Gu, P., Min, J.N., Wang, Y., Huang, C., Peng, T., Chai, W., Chang, S., CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustion. EMBO J. 31:10 (2012), 2309–2321.
21. [21] Stewart, J.A., Wang, F., Chaiken, M.F., Kasbek, C., Chastain, P.D. 2nd, Wright, W.E., Price, C.M., Human CST promotes telomere duplex replication and general replication restart after fork stalling. EMBO J. 31:17 (2012), 3537–3549.
22. [22] Chen, L.Y., Redon, S., Lingner, J., The human CST complex is a terminator of telomerase activity. Nature 488:7412 (2012), 540–544.
23. [23] Anderson, B.H., Kasher, P.R., Mayer, J., Szynkiewicz, M., Jenkinson, E.M., Bhaskar, S.S., Urquhart, J.E., Daly, S.B., Dickerson, J.E., O'Sullivan, J., Leibundgut, E.O., Muter, J., Abdel-Salem, G.M., Babul-Hirji, R., Baxter, P., Berger, A., Bonafe, L., Brunstom-Hernandez, J.E., Buckard, J.A., Chitayat, D., Chong, W.K., Cordelli, D.M., Ferreira, P., Fluss, J., Forrest, E.H., Franzoni, E., Garone, C., Hammans, S.R., Houge, G., Hughes, I., Jacquemont, S., Jeannet, P.Y., Jefferson, R.J., Kumar, R., Kutschke, G., Lundberg, S., Lourenco, C.M., Mehta, R., Naidu, S., Nischal, K.K., Nunes, L., Ounap, K., Philippart, M., Prabhakar, P., Risen, S.R., Schiffmann, R., Soh, C., Stephenson, J.B., Stewart, H., Stone, J., Tolmie, J.L., van der Knaap, M.S., Vieira, J.P., Vilain, C.N., Wakeling, E.L., Wermenbol, V., Whitney, A., Lovell, S.C., Meyer, S., Livingston, J.H., Baerlocher, G.M., Black, G.C., Rice, G.I., Crow, Y.J., Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat. Genet. 44:3 (2012), 338–342.
24. [24] Keller, R.B., Gagne, K.E., Usmani, G.N., Asdourian, G.K., Williams, D.A., Hofmann, I., Agarwal, S., CTC1 mutations in a patient with dyskeratosis congenita. Pediatr. Blood Cancer 59:2 (2012), 311–314.
25. [25] Walne, A.J., Bhagat, T., Kirwan, M., Gitiaux, C., Desguerre, I., Leonard, N., Nogales, E., Vulliamy, T., Dokal, I.S., Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica 98:3 (2013), 334–338.
26. [26] Polvi, A., Linnankivi, T., Kivela, T., Herva, R., Keating, J.P., Makitie, O., Pareyson, D., Vainionpaa, L., Lahtinen, J., Hovatta, I., Pihko, H., Lehesjoki, A.E., Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts. Am. J. Hum. Genet. 90:3 (2012), 540–549.
27. [27] Azzalin, C.M., Reichenbach, P., Khoriauli, L., Giulotto, E., Lingner, J., Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318:5851 (2007), 798–801.
28. [28] Azzalin, C.M., Lingner, J., Telomere functions grounding on TERRA firma. Trends Cell Biol. 25:1 (2015), 29–36.
29. [29] Schoeftner, S., Blasco, M.A., Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell Biol. 10:2 (2008), 228–236.
30. [30] Porro, A., Feuerhahn, S., Delafontaine, J., Riethman, H., Rougemont, J., Lingner, J., Functional characterization of the TERRA transcriptome at damaged telomeres. Nat. Commun., 5, 2014, 5379.
31. [31] Porro, A., Feuerhahn, S., Lingner, J., TERRA-reinforced association of LSD1 with MRE11 promotes processing of uncapped telomeres. Cell Rep. 6:4 (2014), 765–776.
32. [32] Flynn, R.L., Centore, R.C., O'Sullivan, R.J., Rai, R., Tse, A., Songyang, Z., Chang, S., Karlseder, J., Zou, L., TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature 471:7339 (2011), 532–536.
33. [33] Redon, S., Reichenbach, P., Lingner, J., The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res. 38:17 (2010), 5797–5806.
34. [34] Pfeiffer, V., Lingner, J., TERRA promotes telomere shortening through exonuclease 1-mediated resection of chromosome ends. PLoS Genet., 8(6), 2012, e1002747.
35. [35] Yehezkel, S., Segev, Y., Viegas-Pequignot, E., Skorecki, K., Selig, S., Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum. Mol. Genet. 17:18 (2008), 2776–2789.
36. [36] Paeschke, K., Capra, J.A., Zakian, V.A., DNA replication through G-quadruplex motifs is promoted by the Saccharomyces cerevisiae Pif1 DNA helicase. Cell 145:5 (2011), 678–691.
37. [37] Vannier, J.B., Pavicic-Kaltenbrunner, V., Petalcorin, M.I., Ding, H., Boulton, S.J., RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 149:4 (2012), 795–806.
38. [38] Crabbe, L., Verdun, R.E., Haggblom, C.I., Karlseder, J., Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 306:5703 (2004), 1951–1953.
39. [39] Ding, H., Schertzer, M., Wu, X., Gertsenstein, M., Selig, S., Kammori, M., Pourvali, R., Poon, S., Vulto, I., Chavez, E., Tam, P.P., Nagy, A., Lansdorp, P.M., Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell 117:7 (2004), 873–886.
40. [40] Sarek, G., Vannier, J.B., Panier, S., Petrini, J.H., Boulton, S.J., TRF2 recruits RTEL1 to telomeres in S phase to promote t-loop unwinding. Mol. Cell 57:4 (2015), 622–635.
41. [41] Griffith, J.D., Comeau, L., Rosenfield, S., Stansel, R.M., Bianchi, A., Moss, H., de Lange, T., Mammalian telomeres end in a large duplex loop. Cell 97:4 (1999), 503–514.
42. [42] Grolimund, L., Aeby, E., Hamelin, R., Armand, F., Chiappe, D., Moniatte, M., Lingner, J., A quantitative telomeric chromatin isolation protocol identifies different telomeric states. Nat. Commun., 4, 2013, 2848.
43. [43] Pfeiffer, V., Crittin, J., Grolimund, L., Lingner, J., The THO complex component Thp2 counteracts telomeric R-loops and telomere shortening. EMBO J. 32:21 (2013), 2861–2871.
44. [44] Hahn, W.C., Dessain, S.K., Brooks, M.W., King, J.E., Elenbaas, B., Sabatini, D.M., DeCaprio, J.A., Weinberg, R.A., Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22:7 (2002), 2111–2123.
45. [45] Ducrest, A.L., Amacker, M., Mathieu, Y.D., Cuthbert, A.P., Trott, D.A., Newbold, R.F., Nabholz, M., Lingner, J., Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res. 61:20 (2001), 7594–7602.
46. [46] Cristofari, G., Lingner, J., Telomere length homeostasis requires that telomerase levels are limiting. EMBO J. 25:3 (2006), 565–574.
47. [47] Ong, S.E., Blagoev, B., Kratchmarova, I., Kristensen, D.B., Steen, H., Pandey, A., Mann, M., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 1:5 (2002), 376–386.
48. [48] Bendall, S.C., Hughes, C., Stewart, M.H., Doble, B., Bhatia, M., Lajoie, G.A., Prevention of amino acid conversion in SILAC experiments with embryonic stem cells. Mol. Cell. Proteomics 7:9 (2008), 1587–1597.
49. [49] Cox, J., Mann, M., MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26:12 (2008), 1367–1372.
50. [50] Cox, J., Neuhauser, N., Michalski, A., Scheltema, R.A., Olsen, J.V., Mann, M., Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10:4 (2011), 1794–1805.
51. [51] Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T., Harris, M.A., Hill, D.P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J.C., Richardson, J.E., Ringwald, M., Rubin, G.M., Sherlock, G., Gene ontology: tool for the unification of biology, The Gene Ontology Consortium. Nat. Genet. 25:1 (2000), 25–29.
52. [52] Kanehisa, M., Goto, S., KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:1 (2000), 27–30.
53. [53] Yi, E.C., Li, X.J., Cooke, K., Lee, H., Raught, B., Page, A., Aneliunas, V., Hieter, P., Goodlett, D.R., Aebersold, R., Increased quantitative proteome coverage with (13)C/(12)C-based, acid-cleavable isotope-coded affinity tag reagent and modified data acquisition scheme. Proteomics 5:2 (2005), 380–387.
54. [54] Zeng, P.Y., Vakoc, C.R., Chen, Z.C., Blobel, G.A., Berger, S.L., In vivo dual cross-linking for identification of indirect DNA-associated proteins by chromatin immunoprecipitation. BioTechniques, 41(6), 2006, 694 696, 698.
55. [55] Kurdistani, S.K., Grunstein, M., In vivo protein-protein and protein-DNA crosslinking for genomewide binding microarray. Methods 31:1 (2003), 90–95.
56. [56] Dejardin, J., Kingston, R.E., Purification of proteins associated with specific genomic Loci. Cell 136:1 (2009), 175–186.